| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3885 |
| Trial ID | NCT06420154 |
| Disease | Systemic Lupus Erythematosus | Sjogren's Syndrome | Systemic Sclerosis | Inflammatory Myopathy | Vasculitis | Antiphospholipid Syndrome |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | An Exploratory Clinical Study to Evaluating the Safety and Efficacy of Infusiing Anti-CD19-CAR-T Cells Injection (Anti-CD19-CAR-T Cells) in Patients With Relapsed/Refractory Autoimmune Diseases |
| Year | 2024 |
| Country | China |
| Company sponsor | First Affiliated Hospital of Wenzhou Medical University |
| Other ID(s) | CD19-CN-A4 |
| Cohort 1 | |||||||||||||
|
|||||||||||||